Side-by-side comparison
Pentadeca Arginate (PDA) vs GHRP-1
Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair. versus First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- ✓Tendon and ligament healing
- ✓Better stability than BPC-157 acetate
- ✓Anti-inflammatory
GHRP-1
PerformanceFirst-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Top benefits
- ✓Stimulates pituitary GH release
- ✓Synergizes with GHRH analogs
- ✓Lean mass support
| Attribute | Pentadeca Arginate (PDA) | GHRP-1 |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | linear |
| Chain length | 15 aa | 7 aa |
| Formula | BPC-157 arginate salt | C46H56N12O6 |
| Common dose | 250-500 mcg | 100-300 mcg |
| Frequency | 1-2x daily SC | 1-3x daily |
| Top benefit | Tendon and ligament healing | Stimulates pituitary GH release |
| Top side-effect | Injection-site irritation | Mild cortisol/prolactin rise |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.